Abstract #0245

Axon Loss as an Outcome Measure for Assessing Therapeutic Efficacy

Tsen-Hsuan Lin¹, Mitchell Hallman^1,2, Mattew F. Cusick³, Jane E. Libbey³, Peng Sun¹, Yong Wang^1,4,5,6, Robert S. Fujinami³, and Sheng-Kwei Song^1,5,6

¹Radiology, Washington University School of Medicine, St. Louis, MO, United States, ²Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States, ³Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States, ⁴Obstertic and Gynecology, Washington University School of Medicine, St. Louis, MO, United States, ⁵The Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, United States, ⁶Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, United States

Diffusion basis spectrum imaging (DBSI) has successfully distinguished co-existing pathologies in CNS, such as MS. The utility of DBSI derived “axon volume” has not been explored previously. In this study, we demonstrated the use of axon loss, reflecting irreversible tissue damage, as an outcome measure for assessing therapeutic efficacy in a mouse model of multiple sclerosis.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.